Clinical Trial Update: Study of Oxaliplatin, Irinotecan, and S-1 in Biliary Tract Cancer [Phase 2]

View source ↗

Summary

Phase 2 study evaluating a combination of oxaliplatin, irinotecan, and S-1 in biliary tract cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer

Drugs mentioned

• Irinotecan (Camptosar) (Irinotecan)
• Oxaliplatin (Eloxatin) (oxaliplatin)
• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Hallym University Medical Center | Conditions: Biliary Tract Neoplasm | Phase 2 | Status: UNKNOWN